Get started
Author

Juul M. Cox

Observed names: Cox, Juul M., Juul M Cox
Institution: Maasstad Ziekenhuis
ORCID: 0000-0002-7102-1090
Observed ORCID: 0000-0002-7102-1090
OpenAlex ID: A5044772198
Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands
2013 · Pieter T. de Boer, Koen B. Pouwels, et al. · Vaccine · 36
The added value of H2 antagonists in premedication regimens during paclitaxel treatment
2021 · Juul M. Cox, Leni van Doorn, et al. · British Journal of Cancer · 28
PDF
Cost–utility analysis of tapering strategies of biologicals in rheumatoid arthritis patients in the Netherlands
2023 · Luuk van Esveld, Juul M Cox, et al. · Annals of the Rheumatic Diseases · 13
PDF
Effect of Switching the Histamine-1 Receptor Antagonist Clemastine to Cetirizine in Paclitaxel Premedication Regimens: The H1-Switch Study
2024 · Ruben Malmberg, Leni van Doorn, et al. · JCO Oncology Practice · 5
PDF
Real-World Adalimumab Trough Levels, Antidrug Antibody Levels, and Disease Activity in Rheumatoid Arthritis
2025 · Juul M. Cox, Hazar El Achaouch, et al. · Therapeutic Drug Monitoring · 2
Severe Diltiazem Poisoning Managed With CytoSorb Hemoadsorption and Supportive Therapies: A Case Report
2026 · Juul M. Cox, Julia A. M. Verwaaijen, et al. · Critical Care Explorations · 1
RANISTOP research shows no added value for antacids:Ranitidine can be safely removed from paclitaxel premedication regimen
2021 · Cox, Juul M., van Doorn, Leni, et al. · EUR Research Repository (Erasmus University Rotterdam)
Works count: 8
Citation count: 85
H-index: 4
I10-index: 3
Year
Topic
Type